These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 36092247)

  • 1. The relationship between patients' income and education and their access to pharmacological chronic pain management: A scoping review.
    Atkins N; Mukhida K
    Can J Pain; 2022; 6(1):142-170. PubMed ID: 36092247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
    Rees S; Williams A
    JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain Management Strategies in Rheumatoid Arthritis: A Narrative Review.
    Sánchez-Flórez JC; Seija-Butnaru D; Valero EG; Acosta CDPA; Amaya S
    J Pain Palliat Care Pharmacother; 2021 Dec; 35(4):291-299. PubMed ID: 34623946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis.
    Roodenrijs NMT; Hamar A; Kedves M; Nagy G; van Laar JM; van der Heijde D; Welsing PMJ
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33419871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT.
    Brown S; Everett CC; Naraghi K; Davies C; Dawkins B; Hulme C; McCabe C; Pavitt S; Emery P; Sharples L; Buch MH
    Health Technol Assess; 2018 Jun; 22(34):1-280. PubMed ID: 29900829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies.
    Lalor AF; Brooker JE; Rozbroj T; Whittle SL; Hill CL; Rowett D; Buchbinder R; O'Connor DA
    Semin Arthritis Rheum; 2022 Aug; 55():151988. PubMed ID: 35286905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.
    Heather EM; Payne K; Harrison M; Symmons DP
    Pharmacoeconomics; 2014 Feb; 32(2):109-34. PubMed ID: 24338344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic Status and Medication Use in Rheumatoid Arthritis: A Scoping Review.
    Russell O; Lester S; Black RJ; Hill CL
    Arthritis Care Res (Hoboken); 2023 Jan; 75(1):92-100. PubMed ID: 36106932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inequities in access to biologic and synthetic DMARDs across 46 European countries.
    Putrik P; Ramiro S; Kvien TK; Sokka T; Pavlova M; Uhlig T; Boonen A;
    Ann Rheum Dis; 2014 Jan; 73(1):198-206. PubMed ID: 23467636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sociodemographic Determinants of Out-of-Pocket Expenditures for Patients Using Prescription Drugs for Rheumatoid Arthritis.
    Mukherjee K; Kamal KM
    Am Health Drug Benefits; 2017 Feb; 10(1):7-15. PubMed ID: 28465764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world effectiveness of biological therapy in patients with rheumatoid arthritis: Systematic review and meta-analysis.
    de Castro CT; de Queiroz MJ; Albuquerque FC; Brandão CC; Gerlack LF; Pereira DCR; Barros SC; Andrade WW; Bastos EA; Azevedo JNB; Carreiro R; Barreto ML; Dos Santos DB
    Front Pharmacol; 2022; 13():927179. PubMed ID: 36034836
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis.
    Kerschbaumer A; Sepriano A; Smolen JS; van der Heijde D; Dougados M; van Vollenhoven R; McInnes IB; Bijlsma JWJ; Burmester GR; de Wit M; Falzon L; Landewé R
    Ann Rheum Dis; 2020 Jun; 79(6):744-759. PubMed ID: 32033937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health Care Effect of Disease-Modifying Antirheumatic Drug Use on Patients with Rheumatoid Arthritis.
    Boytsov NN; Bhattacharya R; Saverno K; Dixon L; Abbott PL; Zhang X; Gaich CL; Nair R
    J Manag Care Spec Pharm; 2019 Aug; 25(8):879-887. PubMed ID: 31347977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
    Ramiro S; Radner H; van der Heijde D; van Tubergen A; Buchbinder R; Aletaha D; Landewé RB
    Cochrane Database Syst Rev; 2011 Oct; (10):CD008886. PubMed ID: 21975788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents.
    Eccleston C; Cooper TE; Fisher E; Anderson B; Wilkinson NM
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012537. PubMed ID: 28770976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of multidomain management strategies by community dwelling adults with chronic pain: evidence from a systematic review.
    Axon DR; Patel MJ; Martin JR; Slack MK
    Scand J Pain; 2019 Jan; 19(1):9-23. PubMed ID: 30375350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled trial of tumour necrosis factor inhibitors against combination intensive therapy with conventional disease-modifying antirheumatic drugs in established rheumatoid arthritis: the TACIT trial and associated systematic reviews.
    Scott DL; Ibrahim F; Farewell V; O'Keeffe AG; Ma M; Walker D; Heslin M; Patel A; Kingsley G
    Health Technol Assess; 2014 Oct; 18(66):i-xxiv, 1-164. PubMed ID: 25351370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.
    Stevenson M; Archer R; Tosh J; Simpson E; Everson-Hock E; Stevens J; Hernandez-Alava M; Paisley S; Dickinson K; Scott D; Young A; Wailoo A
    Health Technol Assess; 2016 Apr; 20(35):1-610. PubMed ID: 27140438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].
    Noufi P; Khoury E; Ayoub E; Naccache N; Richa S
    Encephale; 2016 Dec; 42(6):511-516. PubMed ID: 27776797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.